Pressmeddelande -

TATAA Biocenter Announces the Opening of New GLP Compliant Laboratory in Gothenburg, Sweden

TATAA Biocenter, an industry-leading nucleic acid analysis services provider, is excited to announce the opening of a Good Laboratory Practice (GLP) compliant facility in Gothenburg, Sweden. The new facility, which is set to open on December 3rd, 2021, will specialize in quality control (QC) analytics to better support the needs of gene and cell therapeutics.

By specializing in QC analytics, TATAA is hoping to address unmet needs within nucleic acid-based drugs, especially within gene and cell therapies, where impurities in the product could pose significant risk and danger to patients’ lives. Unlike traditional contract research organizations and established laboratories, TATAA differentiates itself by offering new methods that meet the sensitivity requirements necessary for robust molecular analyses for these projects. TATAA’s new 2,000-square-meter facility is customized to minimize contamination and optimize their laboratory workflow.

“We’re offering innovative methods for quality control of gene and cell therapeutics, and these are based on qPCR, digital PCR and next-generation sequencing. We’re the first lab with this focus, which is our core competence since 20 years,” says Mikael Kubista, Ph.D., CEO and Founder of the TATAA Biocenter.

The new GLP facility complements TATAA’s existing ISO 17025:2018 accreditation. TATAA will continue to design and validate custom assays for their customers and are excited to enhance their existing services by tracing samples throughout the analytical process. TATAA also provides routine product testing, courses, and contamination-prevention consulting.

Relaterade länkar

Ämnen

  • Hälsa, sjukvård, läkemedel

Kategorier

  • #tataa
  • #gcp
  • #cro
  • #ngs
  • #pharma
  • #glp

TATAA Biocenter is leading provider of molecular service as center to the Advanced Therapies and Medical products (ATMP) industry in Europe and the Cell and Gene Therapy in the United States. With ISO 17025 accreditation and Good Laboratory and Clinical Practices (GLP/GCP) TATAA is perfectly positioned to support the pharmaceutical industry with biomarker profiling including genomics, transcriptomics, proteomics and microbiomics with traditional qPCR, dPCR and NGS methods as well as proprietary methods such as Two-Tailed PCR and Direct Blood Genotyping.

Kontakter

Mikael Kubista

Presskontakt CEO Cell and Gene Therapy +46733928168

Romina Cifliku

Presskontakt Project Manager +46 728815843

Relaterad media

  • 20211117_JennyJacobsson_TATAA_0109.tif
  • Licens: Icke kommersiell användning
    Innehållet får laddas ner, användas och delas med andra, så länge Innehållet används oförändrat, i dess helhet och i icke kommersiellt syfte. Upphovsmannen ska anges i den omfattning och på det sätt god sed kräver (vilket bl.a. innebär att fotografer till bilder nästan alltid måste anges).
Ladda ner

Relaterat innehåll

TATAA Biocenter listed as one of Sweden's fastest growing tech companies

TATAA Biocenter is listed as one of Sweden's fastest growing tech companies by accounting firm Deloitte. Sweden Technology Fast 50 includes public and private companies in all areas of technology, from software and hardware to life science, communications and clean technology. The ranking is based on the companies average revenue increase during a 4-year period.

TATAA Biocenter named “Best Nucleic Acid Analysis Service Provider in Europe” by Global Health & Pharma

Global Health & Pharma, a British information platform supporting a community of over 250,000 in the health, veterinary and environmental areas, has named Swedish service provider TATAA Biocenter AB “Best Nucleic Acid Analysis Service Provider in Europe”.
“We are excited at being the no.1 service provider in Europe. This shows our focus on delivering highest quality results based on careful

TATAA Biocenter and BTU develops Two-tailed PCR for microRNA analysis offering superior sensitivity and specificity.

TATAA Biocenter and the Institute of Biotechnology, BIOCEV, have developed Two-Tailed PCR for ultrasensitive analysis of microRNAs based on products from Roche. Based on an innovative novel design with a RT primer sensing the microRNA using two connected hemi-probes exceeding sensitivity and superior specificity is achieved. The results of the work appeared in this week’s issue of the prestigious

Frost & Sullivan Recognizes TATAA Biocenter's Complete, Best-in-Class Services for Analyzing Genetic Material

LONDON, Aug. 20, 2013 /PRNewswire/ -- Based on its recent research on the gene expression profiling services market, Frost & Sullivan presents TATAA Biocenter with the 2013 European Frost & Sullivan Award for Customer Value Leadership. TATAA Biocenter offers an end-to-end range of services for analyzing genetic material, from quantitative reverse transcription polymerase chain reaction (qR

TATAA Biocenter Expands its Digital PCR offerings with Bio-Rad’s Droplet Digital PCR System

TATAA Biocenter, Europe´s leading provider of genomic services, is expanding its digital PCR offerings with Bio-Rad’s high-throughput QX200™ Droplet Digital™ PCR system (ddPCR™). In 2007 TATAA Biocenter became the first company in Europe to provide digital PCR services to researchers and published one of the first papers that featured an application of digital PCR on a high throughput platform (Nu